Jazz Pharmaceuticals plc (JAZZ)
Data as of , from SEC Form 4 filings.
Net insider selling (90d)Watch JAZZ
See up to 3 months of JAZZ. The 7-day demo opens the 1M and 3M ranges and puts JAZZ on your watchlist.
Start 7-day demoLatest JAZZ insider trades
- Renee D. Gala - OfficerOpen-market sale$473K
Bruce C. Cozadd - DirectorOpen-market sale$1.38M
About Jazz Pharmaceuticals plc (JAZZ)
Jazz Pharmaceuticals plc is an SEC registrant, filing under CIK 0001232524, classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
JAZZ Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 12 | 100,121 | $24.86M |
| Grant or award | 11 | 17,655 | |
| Option exercise | 8 | 115,000 | |
JAZZ insider transactions (Form 4)
82107 Form 4 filings on record, the earliest from Nov 5, 2024, newest first. Filing history page 3 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Patricia Carr - Officer | Open-market sale | Ordinary Shares | 1,117 | $190.91 | $213K | |
| Patricia Carr - Officer | Grant or award | Ordinary Shares | 2,223 | $0.00 | - | |
| Patricia Carr - Officer | Open-market sale | Ordinary Shares | 1,253 | $194.11 footnote F3 | $243K | |
| ||||||
| Renee D. Gala - Officer | Grant or award | Ordinary Shares | 44,465 | $0.00 | - | |
| Ted W. Love - Director | Grant or award | Ordinary Shares | 1,527 | $0.00 | - | |
| Neena M. Patil - Officer | Option exercise | Ordinary Shares | 20,125 | $113.10 | $2.28M | |
| Neena M. Patil - Officer | Option exercise | Ordinary Shares | 875 | $113.10 | $99K | |
| Neena M. Patil - Officer | Option exercise | Ordinary Shares | 27,084 | $137.12 | $3.71M | |
| Neena M. Patil - Officer | Option exercise | Ordinary Shares | 2,916 | $137.12 | $400K | |
| Neena M. Patil - Officer | Open-market sale | Ordinary Shares | 16,602 | $192.53 footnote F1 | $3.20M | |
| Neena M. Patil - Officer | Open-market sale | Ordinary Shares | 875 | $192.07 footnote F2 | $168K | |
| Neena M. Patil - Officer | Open-market sale | Ordinary Shares | 15,555 | $190.28 footnote F3 | $2.96M | |
| Neena M. Patil - Officer | Open-market sale | Ordinary Shares | 2,916 | $189.81 footnote F4 | $553K | |
| Neena M. Patil - Officer | Grant or award | Ordinary Shares | 10,079 | $0.00 | - | |
| Neena M. Patil - Officer | Open-market sale | Ordinary Shares | 11,529 | $191.65 footnote F6 | $2.21M | |
| Neena M. Patil - Officer | Open-market sale | Ordinary Shares | 3,523 | $193.58 footnote F7 | $682K | |
| Neena M. Patil - Officer | Open-market sale | Ordinary Shares | 1,061 | $190.00 footnote F8 | $202K | |
| Neena M. Patil - Officer | Open-market sale | Ordinary Shares | 549 | $190.80 footnote F9 | $105K | |
| Neena M. Patil - Officer | Open-market sale | Ordinary Shares | 1,784 | $191.88 footnote F10 | $342K | |
| Neena M. Patil - Officer | Open-market sale | Ordinary Shares | 1,009 | $192.79 footnote F11 | $195K | |
| Neena M. Patil - Officer | Open-market sale | Ordinary Shares | 197 | $193.60 footnote F12 | $38K | |
| Neena M. Patil - Officer | Option exercise | Incentive Stock Option (right to buy) | 875 | $0.00 | - | |
| Neena M. Patil - Officer | Option exercise | Incentive Stock Option (right to buy) | 2,916 | $0.00 | - | |
| Neena M. Patil - Officer | Option exercise | Non-Qualified Stock Option (right to buy) | 20,125 | $0.00 | - | |
| Neena M. Patil - Officer | Option exercise | Non-Qualified Stock Option (right to buy) | 27,084 | $0.00 | - | |
| ||||||
| Mary Elizabeth Henderson - Officer | Grant or award | Ordinary Shares | 4,447 | $0.00 | - | |
| Mary Elizabeth Henderson - Officer | Open-market sale | Ordinary Shares | 5,343 | $194.49 footnote F3 | $1.04M | |
| ||||||
| Mary Elizabeth Henderson - Officer | Grant or award | Ordinary Shares | 10,116 | $0.00 | - | |
| Patricia Carr - Officer | Grant or award | Ordinary Shares | 2,370 | $0.00 | - | |
| Neena M. Patil - Officer | Grant or award | Ordinary Shares | 8,852 | $0.00 | - | |
| Neena M. Patil - Officer | Derivative | Ordinary Shares | 3,275 | $171.16 | $561K | |
 Samantha Pearce - Officer | Grant or award | Ordinary Shares | 3,637 | $0.00 | - | |
| Samantha Pearce - Officer | Tax withholding / forfeiture | Ordinary Shares | 1,599 | $171.16 | $274K | |
| Robert Iannone - Officer | Tax withholding / forfeiture | Ordinary Shares | 4,140 | $171.16 | $709K | |
| Robert Iannone - Officer | Grant or award | Ordinary Shares | 11,699 | $0.00 | - | |
| Renee D. Gala - Officer | Grant or award | Ordinary Shares | 12,741 | $0.00 | - | |
| Renee D. Gala - Officer | Tax withholding / forfeiture | Ordinary Shares | 5,371 | $171.16 | $919K | |
| Bruce C. Cozadd - Director | Grant or award | Ordinary Shares | 35,917 | $0.00 | - | |
| Bruce C. Cozadd - Director | Tax withholding / forfeiture | Ordinary Shares | 17,453 | $171.16 | $2.99M | |
 Kenneth W. O'Keefe - Director | Tax withholding / forfeiture | Ordinary Shares | 603 | $173.07 | $104K | |
| Bruce C. Cozadd - Director | Option exercise | Ordinary Shares | 76,689 | $123.36 | $9.46M | |
| Bruce C. Cozadd - Director | Option exercise | Ordinary Shares | 811 | $123.36 | $100K | |
| Bruce C. Cozadd - Director | Open-market sale | Ordinary Shares | 30,487 | $178.06 footnote F1 | $5.43M | |
| Bruce C. Cozadd - Director | Open-market sale | Ordinary Shares | 8,380 | $179.23 footnote F2 | $1.50M | |
| Bruce C. Cozadd - Director | Open-market sale | Ordinary Shares | 507 | $179.79 footnote F3 | $91K | |
| Bruce C. Cozadd - Director | Open-market sale | Ordinary Shares | 38,126 | $177.27 footnote F4 | $6.76M | |
| Bruce C. Cozadd - Director | Option exercise | Incentive Stock Option (right to buy) | 811 | $0.00 | - | |
| Bruce C. Cozadd - Director | Option exercise | Non-Qualified Stock Option (right to buy) | 76,689 | $0.00 | - | |
| ||||||
| Heather Ann McSharry - Director | Option exercise | Ordinary Shares | 3,415 | $138.08 | $472K | |
| Heather Ann McSharry - Director | Open-market sale | Ordinary Shares | 3,415 | $177.78 | $607K | |
| Heather Ann McSharry - Director | Option exercise | Non-Qualified Stock Option (right to buy) | 3,415 | $0.00 | - | |
| Mary Elizabeth Henderson - Officer | Derivative | Ordinary Shares | 1,331 | $180.40 | $240K | |
| Patricia Carr - Officer | Option exercise | Ordinary Shares | 5,250 | $136.18 | $715K | |
| Patricia Carr - Officer | Open-market sale | Ordinary Shares | 5,250 | $182.07 | $956K | |
| Patricia Carr - Officer | Open-market sale | Ordinary Shares | 69 | $181.66 | $13K | |
| Patricia Carr - Officer | Option exercise | Non-Qualified Stock Option (right to buy) | 5,250 | $0.00 | - | |
| Rick E. Winningham - Director | Open-market sale | Ordinary Shares | 5,500 | $180.86 | $995K | |
| Bruce C. Cozadd - Director | Open-market sale | Ordinary Shares | 717 | $182.60 footnote F4 | $131K | |
| Bruce C. Cozadd - Director | Grant or award | Ordinary Shares | 2,506 | $0.00 | - | |
| Bruce C. Cozadd - Director | Open-market sale | Ordinary Shares | 3,384 | $180.09 footnote F1 | $609K | |
| Bruce C. Cozadd - Director | Open-market sale | Ordinary Shares | 8,382 | $180.88 footnote F2 | $1.52M | |
| Bruce C. Cozadd - Director | Open-market sale | Ordinary Shares | 5,517 | $181.81 footnote F3 | $1.00M | |
| ||||||
| Robert Iannone - Officer | Open-market sale | Ordinary Shares | 7,159 | $168.26 | $1.20M | |
| Bruce C. Cozadd - Director | Open-market sale | Ordinary Shares | 2,000 | $131.78 | $264K | |
| Bruce C. Cozadd - Director | Open-market sale | Ordinary Shares | 3,500 | $140.00 | $490K | |
| Bruce C. Cozadd - Director | Tax withholding / forfeiture | Ordinary Shares | 15,647 | $126.16 | $1.97M | |
| Bruce C. Cozadd - Director | Open-market sale | Ordinary Shares | 3,000 | $127.23 | $382K | |
| Bruce C. Cozadd - Director | Open-market sale | Ordinary Shares | 3,000 | $130.00 | $390K | |
| Kenneth W. O'Keefe - Director | Grant or award | Ordinary Shares | 3,507 | $0.00 | - | |
| Kenneth W. O'Keefe - Director | Tax withholding / forfeiture | Ordinary Shares | 1,805 | $111.25 | $201K | |
| Jennifer E. Cook - Director | Grant or award | Ordinary Shares | 3,507 | $0.00 | - | |
| Jennifer E. Cook - Director | Tax withholding / forfeiture | Ordinary Shares | 1,805 | $111.25 | $201K | |
| Patrick G. Enright - Director | Grant or award | Ordinary Shares | 3,507 | $0.00 | - | |
| Patrick G. Enright - Director | Tax withholding / forfeiture | Ordinary Shares | 1,805 | $111.25 | $201K | |
| Patrick Kennedy - Director | Grant or award | Ordinary Shares | 3,507 | $0.00 | - | |
| Patrick Kennedy - Director | Tax withholding / forfeiture | Ordinary Shares | 1,959 | $111.25 | $218K | |
| Laura Hamill - Director | Grant or award | Ordinary Shares | 3,507 | $0.00 | - | |
| Laura Hamill - Director | Tax withholding / forfeiture | Ordinary Shares | 1,805 | $111.25 | $201K | |
| Heather Ann McSharry - Director | Grant or award | Ordinary Shares | 3,507 | $0.00 | - | |
| Heather Ann McSharry - Director | Tax withholding / forfeiture | Ordinary Shares | 1,959 | $111.25 | $218K | |
| Anne Oriordan - Director | Grant or award | Ordinary Shares | 3,507 | $0.00 | - | |
| Anne Oriordan - Director | Tax withholding / forfeiture | Ordinary Shares | 1,805 | $111.25 | $201K | |
See every JAZZ filing on record
These pages show the latest 90 of 107 Form 4 filings on record. The 7-day demo shows all 107, and sign-up brings you back to this table.
Item 5.02
Item 1.01, 2.03, 9.01
Item 7.01
Item 1.01, 2.03, 3.02, 8.01, 9.01
Recent JAZZ Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| ANNE O'RIORDAN | Director | 14,687 | $3.36M | View on EDGAR | |
| RENEE D GALA | Officer | 2,000 |
JAZZ insider trading FAQ
What is the latest insider trade for JAZZ?
Jazz Pharmaceuticals plc (JAZZ) had 30 insider filings in the last 90 days, with the most recent on 2026-10-07. The full record for JAZZ runs to 107 Form 4 filings, the earliest from 2024-11-05. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying JAZZ stock?
No insider purchases of JAZZ were filed in the last 90 days. 4 purchases are on record for this company.
How many insiders are selling JAZZ stock?
12 insider sales of JAZZ were filed in the last 90 days, totaling $24.86M.
Where can I see JAZZ SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects JAZZ Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Renee D. Gala view on EDGAR
- - Bruce C. Cozadd view on EDGAR
- - Neena M. Patil view on EDGAR
- - Renee D. Gala view on EDGAR
- - Mary Elizabeth Henderson view on EDGAR
- - Mary Elizabeth Henderson view on EDGAR
- - Mark Douglas Smith view on EDGAR
- - Norbert G. Riedel view on EDGAR
- - Ted W. Love view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where JAZZ's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow JAZZ with a 7-day demo
- JAZZ on your watchlist
- Every JAZZ Form 4 filing on record
- Up to 3 months of JAZZ price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
